Focus
Antipsychotic Drugs
Study Urges Doctors to Rethink Prescribing Antipsychotics for Dementia Patients
Antipsychotics pose greater health risks than previously understood, leading to severe complications in dementia patients.
Remission From ‘Treatment-Resistant’ Schizophrenia Possible With Underutilized Drug: Psychiatrist
Bethany Yeiser is now free of severe schizophrenia symptoms after starting clozapine in 2008, allowing her to graduate college and start the CURESZ Foundation.
An Antipsychotic Drug Gets FDA Green Light Despite Fourfold Higher Risk of Death
For medical professionals, the FDA’s move raises troubling questions about efficacy, safety, and regulatory diligence.
